ZALICUS PHARMACEUTICALS

zalicus-pharmaceuticals-logo

Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.

#SimilarOrganizations #Website #More

ZALICUS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2009-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.zalicus.com

Total Employee:
11+

Status:
Active

Contact:
+1-604-909-2530


Similar Organizations

not_available_image

Aerogen, Inc.

Aerogen, Inc. operates as a specialty pharmaceutical company that develops, manufactures, and commercializes pulmonary.

alcasynn-pharmaceuticals-gmbh-logo

AlcaSynn Pharmaceuticals GmbH

Drug development company focusing on small molecules of the morphinan group. In 2006 AlcaSynn was acquired by Sanochemia Pharmazeutika

altum-pharmaceuticals-logo

Altum Pharmaceuticals

Altum Pharmaceuticals operates as a biopharmaceutical company.

avenzoar-pharmaceuticals-logo

Avenzoar Pharmaceuticals

Avenzoar Pharmaceuticals is a pharmaceutical company developing cancer drugs.

not_available_image

Maxim Pharmaceuticals

Maxim Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative cancer therapeutics.

p2d-bioscience-logo

P2D Bioscience

This company is a specialty pharmaceutical company focused on developing innovative drugs.

patrin-pharma-logo

Patrin Pharma

Patrin Pharma is a pharmaceutical company that develops a portfolio of niche generic products.

rivus-pharmaceuticals-logo

Rivus Pharmaceuticals

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

wex-pharmacetuicals-logo

Wex Pharmacetuicals

WEX Pharmaceuticals Inc. is a biopharmaceutical company that developing a late-stage non-opioid analgesic.

Official Site Inspections

http://www.zalicus.com

  • Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
  • IP address: 13.56.33.8
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Zalicus.com lookup results from whois.PublicDomainRegistry.com server:
  • Domain created: 3rd-Jun-2010
  • Domain updated: 11th-Jan-2024
  • Domain expires: 3rd-Jun-2025 0 Years, 58 Days left
  • Website age: 14 Years, 307 Days
  • Registrar Domain ID: 1600403267_DOMAIN_COM-VRSN
  • Registrar Url: http://www.publicdomainregistry.com
  • Registrar WHOIS Server: whois.PublicDomainRegistry.com
  • Registrar Abuse Contact Email: abuse-contact@publicdomainregistry.com
  • Registrar Abuse Contact Phone: +1.2013775952
  • Name server:
    • NS1.BRANDBUCKET.COM
    • NS2.BRANDBUCKET.COM

More informations about "Zalicus Pharmaceuticals"

Zalicus Company Profile 2024: Valuation, Investors, …

Information on acquisition, funding, cap tables, investors, and executives for Zalicus. Use the PitchBook Platform to explore the full profile.See details»

Zalicus Pharmaceuticals - Crunchbase Company Profile …

Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.See details»

Zalicus - Products, Competitors, Financials, Employees, …

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease …See details»

Zalicus Inc. - VentureRadar

"Zalicus Inc., is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immune-inflammatory diseases. The company applies its …See details»

Zalicus, Inc. - Drug pipelines, Patents, Clinical trials - Patsnap

Explore Zalicus, Inc. with its drug pipeline, therapeutic area, technology platform, 22 clinical trials, 13 news, and 35 literature, Disease Domain:Endocrinology and ...See details»

Zalicus - Contacts, Employees, Board Members, Advisors & Alumni

Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»

Organization | Zalicus - Purdue University

Acquisitions Trial Sponsor Other Trial Involvement2012See details»

CombinatoRx Changes Company Name to Zalicus Inc. - Fierce …

Sep 9, 2010 Zalicus utilizes proprietary drug design and electrophysiological screening processes to create drug candidates with improved levels of specificity, enabling the discovery …See details»

Zalicus | Scientist.com

Zalicus is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. Zalicus applies its expertise in the discovery and development of selective …See details»

Zalicus - Funding, Financials, Valuation & Investors

Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»

U.S. arm of Sun Pharma's Taro buys Zalicus ... - Fierce Pharma

Oct 14, 2015 The acquisition of Canada's Zalicus Pharmaceuticals by a U.S. subsidiary of India's largest drugmaker, Sun Pharmaceuticals, is being seen as a move to strengthen its …See details»

Epirus Acquiring Zalicus, Adding Pain Drugs to Product Lineup

Apr 16, 2014 Epirus Biopharmaceuticals said today it will acquire Zalicus, in a deal that adds a pipeline of new product candidates and drug discovery platforms to the acquiring company’s …See details»

Zalicus Inc. | Insights

Latest on Zalicus Inc. Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.See details»

Zalicus Pharmaceuticals - Crunchbase

Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.See details»

Zalicus, Inc.

了解Zalicus, Inc. (Zalicus, Inc.)公司的药物管线,治疗领域,技术平台,以及它的22项临床试验, 15篇新闻和35篇文献,疾病领域:内分泌与代谢疾病,神经系统疾病,感染,免疫系统疾病, …See details»

Zalicus Inc. - VentureRadar

Zalicus Inc., is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immune-inflammatory diseases. The company applies its …See details»

Zalicus Reports Results from Phase 2 Clinical Trials of Z160 in …

Nov 11, 2013 Based on these results, Zalicus is discontinuing the Z160 program and plans to focus efforts on Z944, its novel oral T-type calcium channel modulator in development for the …See details»

Zalicus - Crunchbase

Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»

Zalicus Pharmaceuticals acquired by Taro Pharmaceuticals

Oct 14, 2015 Taro Pharmaceuticals Taro Pharmaceuticals is a research-based pharmaceutical company that develops over-the-counter pharmaceutical products.See details»

linkstock.net © 2022. All rights reserved